Abstracts
5
cancer, renal cell carcinoma, and most recently, head and neck
cancer, truly making it the ‘fourth modality’ of cancer treatment.
This lecture will review FDA-approved agents in the metastatic
setting, highlight the evolving slate of immunotherapy trials cur-
rently accruing patients with head and neck cancer, and explore
future directions for integrating the checkpoint inhibitors and other
therapies into the definitive setting.
http://dx.doi.org/10.1016/j.ijom.2017.02.016Lessons learnt over 25 years of mandibular reconstruction
J. Brown
Aintree University Hospital, Liverpool, United Kingdom
A systematic reviewof reported composite free flap reconstruc-
tion techniques and outcomes has recently been completed and in
press
. 1A total of 9499 mandibular defects were reported to be recon-
structed with 6178 fibulas, 1380 iliac crests, 1127 composite
radials, 709 scapulas, 63 serratus anterior and rib, 32 metatarsals
and 10 lateral arm flaps including humerus. An average of 1.3
osteotomies (1082 osteotomies/856 cases) were described for the
fibula compared to 0.56 (304/544) when using iliac, radial or
scapula. The flap failure rate was higher for the iliac crest at
6.2% (66/1059) compared to 3.4% (202/6018) if the fibula, radial
or scapula was used (
P
< 0.001). The fistula rate of 4.9% for
the fibula (52/1067) was less than the 3 other flaps combined at
6.9% (47/678) [
P
= 0.07]. The non-union rate for fibula was 4.3%
(86/1986) compared to iliac crest at 2.6% (17/646), but the rate was
also high for radial at 6.1% (30/491) and scapula at 13.1% (49/375)
[
P
< 0.001]. Iliac crest was most often rehabilitated with implant-
retained prosthesis (44%, 100/229), compared to 26% (605/2295)
[
P
< 0.001] if another flap was used.
Themain finding in all this workwas that fewpublications were
up to a standard to allow a fair comparison of techniques, types
of defect reconstructed and complications including non-union,
fistula rate and rehabilitation. As shown above the non-union rate
for fibula was 4.3% but the data came from only 32% (1986/6178)
of the flaps reported, which illustrates the lack of valid data in
reconstructive surgery outcomes.
Reference
Brown, J. S., Lowe, D., Kanatas, A., & Schache, A. S. (2017). Mandibular
reconstruction with vascularised bone flaps: a systematic review over 25
years.
Br J Oral Maxillofac Surg
,
55
, 113–126.
http://dx.doi.org/10.1016/j.ijom.2017.02.017Sentinel node biopsy for oral cancer
M. McGurk
Guy’s Hospital, London, United Kingdom
The N0 neck has posed a clinical problem for over four decades.
A comprehensive study from India has shown that elective neck
dissection (END) has a significant survival advantage over a ‘wait
and see’ policy. But only 25% of patients with early oral can-
cer have occult metastasis. By adopting an END policy, 75% of
patients get an unnecessary neck dissection.
Sentinel node biopsy is now a well-established investigative
technique but has only recently been applied to the management
of oral cancer. It completely and succinctly answers the dilemma of
how to manage the N0 neck. It can detect occult metastasis with a
false negative rate of 6–13%. The results of the Sentinel European
Node Trial will be presented with subsequent development is the
technique using intraoperative navigation and fluorescent markers
to reduce the false negative rate to 6–8%. New applications of the
technique will be discussed.
http://dx.doi.org/10.1016/j.ijom.2017.02.018Problems of managing advanced stage oral cancer
R. Ord
University of Maryland, College Park, MD, United States
Advanced stage oral cancer represents Stage III and IV disease
as defined by the tumour-node-metastasis (TNM) system. Studies
have shown that outcomes are poor in these cases but the best
results are given with multi-modality therapy and in the United
States of America the National Comprehensive Cancer Network
guidelines are used as the protocols for therapy. This presentation
will discuss philosophically whether the TNM system is still the
best way to classify advanced disease and which adverse prognos-
tic signs postsurgery truly justify adjuvant therapy. The talk will
also question the true role of chemotherapy and whether recent
trials have justified the resurrection of neoadjuvant chemotherapy.
The outcomes for unresectable or advanced locoregionally
recurrent cancer of the oral cavity have always been very poor usu-
ally representing a palliative approach. However, recently there
have been remarkable results seen with the use of the check-
point inhibitors in melanoma and non-small cell lung cancer, and
these agents are now being tested for head and neck cancers.
Early results with the use of these immune checkpoint inhibitors
PD-1, PD-L1 and PD-L2 have shown great potential and may
revolutionise the management of these patients.
http://dx.doi.org/10.1016/j.ijom.2017.02.019Differential diagnosis of multiple enlargement of salivary
glands
G. Yu
Peking University School of Stomatology, Beijing, China
Immunoglobulin G4 (IgG4)-related sialadenitis (IgG4-RS) is
a component of IgG4-RD. One of its clinical characteristics is
multiple enlargement of salivary glands, which is also seen in
other diseases, such as Sjögren’s syndrome, Kimura’s disease,
sarcoidosis and lymphoma. However, the essence and treatment
principles of these diseases are different. Therefore, differential
diagnosis of multiple enlargement of salivary glands is critical.
Case history and symptoms could provide important clues
for diagnosis. Serious xerostomia is seen in Sjögren’s syndrome.
Diet-induced swelling of SMG (‘meal syndrome’) is the typical
symptom of obstructive sialadenitis due to sialolithiasis. Bilat-
eral painless swelling of submandibular gland is frequently seen
in IgG4-RS. Local skin itching is a common complaint for the
patient with Kimura’s disease.
Clinical examination will show the characteristic appearances
of various diseases. Obvious dryness of mouth and eye with very
low saliva flow rate and Schirmer test value are seen in Sjögren’s
syndrome. Stone may be fond by palpation in sialolithiasis. Mul-
tiple bilateral enlargement of major salivary gland and lacrimal
gland is frequently seen in IgG4-RS. Local coarse skin over the
lesion is one of the clinical sign of Kimura’s disease.




